Business Description
Omkar Pharmachem Ltd
ISIN : INE501C01015
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 1.06 | |||||
Interest Coverage | 9.5 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 50.02 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26 | |||||
3-Year EBITDA Growth Rate | 134.9 | |||||
3-Year EPS without NRI Growth Rate | -5.1 | |||||
3-Year FCF Growth Rate | 134.6 | |||||
3-Year Book Growth Rate | 2.1 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.61 | |||||
9-Day RSI | 95.91 | |||||
14-Day RSI | 90.57 | |||||
6-1 Month Momentum % | 22.96 | |||||
12-1 Month Momentum % | 29.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.9 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.51 | |||||
Days Sales Outstanding | 57.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 0.87 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 51.37 | |||||
Net Margin % | 34.8 | |||||
FCF Margin % | 53.02 | |||||
ROE % | 2.03 | |||||
ROA % | 1.94 | |||||
ROIC % | 2.11 | |||||
ROC (Joel Greenblatt) % | 289.48 | |||||
ROCE % | 3.03 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 152.58 | |||||
PE Ratio without NRI | 152.58 | |||||
Price-to-Owner-Earnings | 147.91 | |||||
PS Ratio | 54.19 | |||||
PB Ratio | 3.12 | |||||
Price-to-Tangible-Book | 3.12 | |||||
Price-to-Free-Cash-Flow | 102.08 | |||||
Price-to-Operating-Cash-Flow | 98.94 | |||||
EV-to-EBIT | 104.56 | |||||
EV-to-EBITDA | 102.77 | |||||
EV-to-Revenue | 54.37 | |||||
EV-to-FCF | 102.55 | |||||
Price-to-Projected-FCF | 3.95 | |||||
Price-to-Graham-Number | 4.6 | |||||
Earnings Yield (Greenblatt) % | 0.96 | |||||
FCF Yield % | 0.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Omkar Pharmachem Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 5.4 | ||
EPS (TTM) (₹) | 0.19 | ||
Beta | 0.39 | ||
Volatility % | 19.16 | ||
14-Day RSI | 90.57 | ||
14-Day ATR (₹) | 0.035951 | ||
20-Day SMA (₹) | 28.99 | ||
12-1 Month Momentum % | 29.84 | ||
52-Week Range (₹) | 21.5 - 28.99 | ||
Shares Outstanding (Mil) | 10.08 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Omkar Pharmachem Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Omkar Pharmachem Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Omkar Pharmachem Ltd Frequently Asked Questions
What is Omkar Pharmachem Ltd(BOM:532167)'s stock price today?
When is next earnings date of Omkar Pharmachem Ltd(BOM:532167)?
Does Omkar Pharmachem Ltd(BOM:532167) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |